HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.

Abstract
Insulin resistance is a cardinal feature of normal pregnancy and excess growth hormone (GH) states, but its underlying mechanism remains enigmatic. We previously found a significant increase in the p85 regulatory subunit of phosphatidylinositol kinase (PI 3-kinase) and striking decrease in IRS-1-associated PI 3-kinase activity in the skeletal muscle of transgenic animals overexpressing human placental growth hormone. Herein, using transgenic mice bearing deletions in p85alpha, p85beta, or insulin-like growth factor-1, we provide novel evidence suggesting that overexpression of p85alpha is a primary mechanism for skeletal muscle insulin resistance in response to GH. We found that the excess in total p85 was entirely accounted for by an increase in the free p85alpha-specific isoform. In mice with a liver-specific deletion in insulin-like growth factor-1, excess GH caused insulin resistance and an increase in skeletal muscle p85alpha, which was completely reversible using a GH-releasing hormone antagonist. To understand the role of p85alpha in GH-induced insulin resistance, we used mice bearing deletions of the genes coding for p85alpha or p85beta, respectively (p85alpha (+/-) and p85beta(-/-)). Wild type and p85beta(-/-) mice developed in vivo insulin resistance and demonstrated overexpression of p85alpha and reduced insulin-stimulated PI 3-kinase activity in skeletal muscle in response to GH. In contrast, p85alpha(+/-)mice retained global insulin sensitivity and PI 3-kinase activity associated with reduced p85alpha expression. These findings demonstrated the importance of increased p85alpha in mediating skeletal muscle insulin resistance in response to GH and suggested a potential role for reducing p85alpha as a therapeutic strategy for enhancing insulin sensitivity in skeletal muscle.
AuthorsLinda A Barbour, Shaikh Mizanoor Rahman, Inga Gurevich, J Wayne Leitner, Stephanie J Fischer, Michael D Roper, Trina A Knotts, Yen Vo, Carrie E McCurdy, Shoshana Yakar, Derek Leroith, C Ronald Kahn, Lewis C Cantley, Jacob E Friedman, Boris Draznin
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 280 Issue 45 Pg. 37489-94 (Nov 11 2005) ISSN: 0021-9258 [Print] United States
PMID16166093 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • IRS1 protein, human
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • PGF protein, human
  • Pgf protein, mouse
  • Phosphoproteins
  • Pregnancy Proteins
  • Protein Subunits
  • Placenta Growth Factor
  • Insulin-Like Growth Factor I
  • Growth Hormone
  • Phosphatidylinositol 3-Kinases
Topics
  • Animals
  • Gene Expression Regulation, Enzymologic
  • Growth Hormone (metabolism)
  • Humans
  • Insulin (metabolism)
  • Insulin Receptor Substrate Proteins
  • Insulin Resistance (physiology)
  • Insulin-Like Growth Factor I (genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Muscle, Skeletal (metabolism)
  • Phosphatidylinositol 3-Kinases (chemistry, metabolism)
  • Phosphoproteins (metabolism)
  • Placenta Growth Factor
  • Pregnancy Proteins
  • Protein Subunits (chemistry, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: